Business
Why the Polynovo (ASX:PNV) share price up 6% higher today // Motley Fool Australia
The Polynovo Ltd (ASX: PNV) share price is soaring higher today. This comes after the company announced an approval of a pivotal trial investigation device exemption (IDE).
During mid-morning trade, shares in the medical device company reached an intra-day high of $2.98. However, the Polynovo share price has since slightly retreated to $2.97, up 6.07% at the time of writing.
Let’s take a look at what Polynovo updated the market with.
FDA approval for clinical trial
Polynovo advised that the United States Food and Drug Administration (FDA) has approved the pivotal trial IDE for NovoSorb BTM. The authorisation allows Polynovo to begin patient recruitment, once various hospital Independent Review Boards grant approval.
Polynovo will…
-
Noosa News22 hours agoSocceroos vs New Zealand, Soccer Ashes first leg, live updates
-
Noosa News21 hours agoHow Clive Palmer’s superyacht secured prime Riverfire real estate
-
Noosa News23 hours agoAustralia’s second-oldest literary journal Meanjin to close
-
Noosa News23 hours agoBen McCormack facing court over dozens of offences in Brisbane seeking evidence